13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-07-14 Event 2026-07-10 SEC 0001123292-26-001010 →

Saadi Ryan H. → Tevogen Bio Holdings Inc. TVGNW

Stake: 59.70% Shares: 3,709,567 CUSIP: 88165K101 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The information set forth in Items 3 and 6 of this Amendment is incorporated into this Item 4 by reference.

Cross-References

Insider Activity (last 365d)
2 transactions
2 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-09-30
DTC 1.00
155,699 shares short · +80.5% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-14 Saadi Ryan H. director, officer, 10%+ owner Award 8,000,000 — —
2026-09-14 Desai Kirti officer Award 750,000 — —

Other 13D/G Filings on Tevogen Bio Holdings Inc.

FiledFormFilerStakeShares
2026-09-16 SCHEDULE 13D/A Desai Kirti 6.30% 992,983 view →
2026-09-16 SCHEDULE 13D/A Saadi Ryan H. — 11,709,567 view →

Other Filings by Saadi Ryan H.

FiledFormIssuerStakeShares
2026-09-16 SCHEDULE 13D/A Tevogen Inc. — 11,709,567 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →